United States News All stories

QuidelOrtho (NASDAQ:QDEL), a global powerhouse in in vitro diagnostics, has announced the acquisition of LEX Diagnostics.

AstraZeneca (NASDAQ:AZN) today announced positive high-level results from its pivotal Phase III MIRANDA trial, evaluating tozorakimab as a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD).

Clearmind Medicine (NASDAQ:CMND), a clinical-stage pharmaceutical company focused on developing novel psychedelic-derived therapies, announced today that its lead candidate, CMND-100, has successfully met the primary safety and tolerability endpoints in its Phase I/IIa clinical trial.

Capital City Bank Group (NASDAQ:CCBG) today reported financial results for the first quarter ended March 31, 2026, delivering a consistent performance characterized by disciplined expense management and improved capital metrics.

Biogen (NASDAQ:BIIB) announced today that it has entered into a definitive agreement to acquire the exclusive Greater China rights for felzartamab from TJ Biopharma.

Surf Air Mobility (NYSE:SRFM), a leading regional air mobility platform, today announced a major upward revision to its financial outlook for the 2026 fiscal year.

Genprex (NASDAQ:GNPX), a clinical-stage gene therapy company, announced today that its collaborators presented compelling preclinical data for its lead drug candidate, Reqorsa® (quaratusugene ozeplasmid), at the American Association for Cancer Research (AACR) Annual Meeting 2026.

Stanley Black & Decker (NYSE:SWK) announced today that recent adjustments to the Section 232 tariff regime—the federal trade policy governing aluminum and steel imports—are not expected to have a material impact on the company’s full-year 2026 financial guidance.

Honeywell (NASDAQ:HON) announced today that it has entered into a definitive agreement to sell its Productivity Solutions and Services (PSS) business to Brady Corporation (NYSE:BRC) for $1.4 billion in an all-cash transaction.

SmartFinancial (NYSE:SMBK), the parent company of SmartBank, today reported net income of $13.7 million, or $0.81 per diluted common share, for the first quarter ended March 31, 2026.

Bank of Hawai‘i (NYSE:BOH) reported a sequential increase in net interest income for the first quarter ended March 31, 2026, as the institution began to realize the benefits of a shifting interest rate environment.

Solidion Technology (NASDAQ:STI), an advanced battery materials provider, has finalized a binding strategic patent monetization agreement with Hilco Global’s IP Services Practice.

Agnico Eagle Mines (NYSE:AEM) and Rupert Resources announced today that they have entered into a definitive arrangement agreement for Agnico Eagle to acquire all remaining outstanding common shares of Rupert.

USA Rare Earth (NASDAQ:USAR) has announced a definitive agreement to acquire Serra Verde Group for a total consideration of approximately $2.8 billion.

Greenwich LifeSciences (NASDAQ:GLSI) today presented a significant update on its clinical progress at the 2026 American Association for Cancer Research (AACR) Annual Meeting.

Ennis (NYSE:EBF), a manufacturer of printed business products and apparel, today announced financial results for the fourth quarter and the full fiscal year ended February 28, 2026.

Cleveland-Cliffs (NYSE:CLF), the largest flat-rolled steel producer in North America, reported a significant sequential increase in operational volume and revenue for the first quarter ended March 31, 2026.

Apple (NASDAQ:AAPL) is facing an accelerated timeline for potential antitrust penalties in India after the nation’s competition watchdog fast-tracked a decision to a final hearing next month.

Oculis Holding (NASDAQ:OCS), a global biopharmaceutical company focused on ophthalmic breakthroughs, announced today the completion of the final patient visits in its DIAMOND Phase 3 clinical program.

Monopar Therapeutics (NASDAQ:MNPR) reported positive topline results from its Phase 3 FoCus study, marking a significant milestone in the development of ALXN1840 for patients with Wilson disease.

Sutro Biopharma (NASDAQ:STRO) unveiled a series of preclinical successes at the 2026 American Association for Cancer Research (AACR) Annual Meeting, reinforcing its leadership in the design of next-generation antibody-drug conjugates (ADCs).

Nanobiotix (NASDAQ:NBTX), a late-clinical stage biotechnology company, announced the presentation of new preclinical data today at the 2026 Annual Meeting of the American Association for Cancer Research (AACR).

State Street Corporation (NYSE:STT) reported a robust start to fiscal 2026, with first-quarter total revenue rising 16% year-over-year to $3.8 billion.

Medicus Pharma (NASDAQ:MDCX), a clinical-stage biopharmaceutical company, announced today that it has submitted an application for Orphan Drug Designation (ODD) to the U.S. Food and Drug Administration (FDA) for its flagship candidate, SkinJect (D-MNA).